Current Signal Transduction Therapy

ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Volume 17 , Issues 3, 2022

This journal supports open access

Back Journal Home

Editorial Board


cstt Editor-in-Chief cstt_eic_yang_001 Yang Jingxuan Department of Medicine The University of Oklahoma Health Science Center Oklahoma City OK USA

Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.

Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.

Jingxuan-Yang@ouhsc.edu
Co-Editor cstt_eic_m-li_001 Li Min Department of Surgery The University of Oklahoma Health Sciences Center Oklahoma City, Ok USA

Dr. Min Li is Professor of Medicine, Surgery, and Cell Biology, and holds the Virginia Kerley Cade Endowed Chair in Cancer Treatment. He is the Director of GI Cancer Research, Department of Medicine, and Vice Chair for Research, Department of Surgery, at The University of Oklahoma Health Sciences Center. He is a leading expert on pancreatic cancer. His research mainly focuses on studying pancreatic cancer (PC) pathogenesis and developing new therapies. Dr. Li’s group has published more than 140 papers, and obtained both federal (3 active NIH R01 grants) and private foundation grants to support his research. He is also a member of many NIH study sections.

Min-Li@ouhsc.edu
Section Editor Zhang Jinwei Institute of Biomedical and Clinical Sciences University of Exeter Medical School Exeter United Kingdom J.Zhang5@exeter.ac.uk Signal Transduction Frontiers Section Editors cstt_ebm_paolillo_001 Paolillo Mayra Department of Drug Sciences Università degli Studi di Pavia Pavia Italy

Dr. Mayra Paolillo is an assistant professor at the Department of Drug Sciences, University of Pavia, Italy (where she coordinates a research group and teaches Toxicology and Applied Pharmacology). She graduated in Pharmaceutical Chemistry in 1990. During her Ph.D. she acquired skills in primary cultures of rat neurons, cell biology and molecular biology techniques. Her research fields deal with cancer infiltration mechanisms, integrins, cancer stem cells and metastasis. Dr. Paolillo has also acquired experience in dynamic, 3D cell culture systems to mimic metabolic pathways and other complex cellular processes.

Signal Transduction Pathways mayra.paolillo@unipv.it
cstt_ebm_jiang_001 Jiang Tao Beijing Tiantan Hospital Capital Medical University Beijing China

Dr. Jiang is the Vice Director of Beijing Neurosurgical Institute and Department of Neurosurgery, Beijing Tiantan Hospital, which is one of the world’s largest neurosurgical centers. Dr. Jiang has more than 20 years’ working experience on both clinical practice and scientific research of neurosurgery, and performs more than 500 cases of neurosurgical operations per year. Dr. Jiang has published more than 100 manuscripts and won more than ten national and provincial awards. Dr. Jiang also serves as Chairman of GBM AGILE Executive Committee China Liaison; Chairman of Society for Neuro-oncology of China, Chinese Medical Doctor Association; Vice Dean of Department of Clinical Oncology, Capital Medical University.

jiangtao_369@163.com Neuroscience
Book Review Editor Li Wenbin Beijing Tiantan Hospital Capital Medical University Beijing China neure55@126.com Editorial Board Members cstt_ebm_Gaber-sh_001 Gaber Mohamed A. Chemistry Department Ain Shams University Cairo Egypt

Dr. M. S. Attia is the head of the scientific research group of the diagnosis of diseases by nano optical sensors in Ain Shams University. He received the professor position in analytical chemistry in 2017. M. S. Attia has About 85 research publications and 6 books have been published in international journals and conferences in the last ten years.

mohd_mostafa@sci.asu.edu.eg mohd_mostafa@sci.asu.edu.eg saidattiasam78@gmail.com
cstt_ebm_pandurangana_001 Pandurangan Ashok K. B.S. Abdur Rahman Crescent Institute of Science and Technology Chennai India

Dr. Ashok Kumar Pandurangan (Associate Professor), works in the school of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, India. He completed his PhD in Biochemistry from the University of Madras, Chennai, India during 2006-2011. Later, he worked as a postdoctoral fellow in Centre for Cancer Research, Children's Hospital Oakland Research Institute (California, USA) in the field of S1PLyase deficiency on colitis associated cancer. Then he worked as postdoctoral fellow in the Department of Nutrition and Dietetics, Universiti of Putra Malaysia, Serdang, Malaysia. He also worked as a Visiting Research Fellow in the Department of Pharmacology, University of Malaya, Kuala Lumpur, Malaysia. He has published over forty-five research and review articles in peer reviewed journals and 7 book chapters. He also received several grants in Malaysia and India.

panduashokkumar@gmail.com ashokkumar.sls@crescent.education
cstt_ebm_arulselvan-p-ah_001 Arulselvan Palanisamy Department of Microbiology Muthayammal College of Arts and Science Tamil Nadu India

Dr. Arulselvan Palanisamy is currently an Adjunct Associate Professor at the Muthayammal Centre for Advanced Research (MCAR), Muthayammal College of Arts and Science, Tamil Nadu, India. He did PhD in Biochemistry from the University of Madras, India in 2009. His research interests are Diabetes and diabetic wound healing, Inflammation and Cancer Biology, Nanomedicine for cancer therapy (Drug delivery system), Natural Products Research for inflammation, diabetes and cancer.

arulbio@gmail.com
cstt_ebm_eleftheriadis-t-as_001 Eleftheriadis Theodoros Orcid Department of Nephrology Faculty of Medicine, School of Health Sciences University of Thessaly Larissa Greece 0000-0001-9302-1633 https://scholar.google.gr/citations?hl=el&user=7S6AEWcAAAAJ teleftheriadis@yahoo.com cstt_ebm_Fernandez-l-ah_001 Fernández-Pérez Leandro Institute for Research in Biomedicine and Health Sciences (IUIBS), Molecular and Translational Pharmacology University of Las Palmas Gran Canaria Las Palmas Spain

Leandro Fernández-Pérez obtained his M.D. at Medical Faculty (University of La Laguna, Spain) in 1985 and his Ph.D in Pharmacology in 1989 from the same university. He currently is Professor of Pharmacology in Medicine and a Senior Scientist (Molecular and Translational Pharmacology-BioPharm group) at the Institute for Research in Biomedicine and Health Sciences (IUIBS) University of Las Palmas of Gran Canaria (Canary Islands, Spain). He is also a reviewer for International Journals with impact factor in the fields of Molecular Pharmacology and Molecular Endocrinology.

leandrofco.fernandez@ulpgc.es
cstt_ebm_liu-ah_001 Liu Mingyang University of Oklahoma Health Sciences Center University of Oklahoma Norman OK USA Mingyang-Liu@ouhsc.edu Diani Erica Department of Pathology and Diagnostic University of Verona Verona Italy erica.diani@univr.it Editorial Board Members cstt_ebm_talib-wh-sa_001 Talib Wamidh H. Department of Clinical Pharmacy and Therapeutics Faculty of Pharmacy Applied Science Private University Amman Jordan

The objective of Dr. Talib research is to design new combination therapies that work in concert to target different steps in cancer development, since cancer development is a multi-step process including the induction of instability in genes, abnormal gene expression, angiogenesis, metastasis, and immune evasion. Thus, using a single agent to target all of these pathways may fail to provide an efficient treatment for cancer. The objective of my research is. Therefore, due to their low toxicity and multiple mechanisms of action, natural products are promising sources to develop new anticancer combination therapies.

w_talib@asu.edu.jo
cstt_ebm_Cho_001 Cho Sung-Gook Department of Biotechnology Korea National University of Transportation Chungju South Korea

Dr. Sung-Gook Cho research objective is to understand the cancer disease. He has experienced working in the areas of (a) molecular and cell biology (b) genetics and cancer biology. During BS and MS courses at the Department of Biology, Kyung Hee University, Seoul, Korea, his research focused on mitotic checkpoint mechanism in cell cycle event. During his PhD training at Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, he studied roles of G-protein-coupled receptors (GPCRs) in cancer development and metastasis in terms of biochemistry, cell biology and mouse genetics. Currently, he works in the Department of biotechnology, Korea National University of Transportation as an Assistant Professor.

chosg@ut.ac.kr
cstt_ebm_sharma-pk_001 Sharma Pradeep K. Indian Institute of Toxicology Research Lucknow India

Dr. Pradeep Kumar Sharma is a Scientist at Council of Scientific and Industrial Research-Indian Institute of Toxicology Research. He obtained his PhD Degree in Biotechnology from Guru Gobind Singh Indraprastha University, New Delhi, India. His research interests focus on the environmental carcinogenesis and cancer therapeutics. Dr. Sharma has served and still serving as a reviewer for various journals of national and international repute in the field of cancer, oxidative stress and toxicology. Dr. Sharma has published several papers in cancer biology and toxicology in various international journals of high impact.

pradeep.sharma@iitr.res.in
cstt_ebm_dorszewska-j_001 Dorszewska Jolanta Department of Neurology Poznan University of Medical Sciences Poznan Poland

Prof. Jolanta Dorszewska– is head of the Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland. She is a lecturer in the National High Medical School in Pila, Polandfrom 2012. She graduated in 1987 from the Poznan University of Medical Sciences, received Ph.D. in neurochemistry (1996) from the Poznan University of Medical Sciences, and got postdoctoral lecturing qualification and became the Associate Professor at Poznan University of Medical Sciences in 2004. She became full Professor in 2016. She has published about 100 publications in journals and books with an H-index = 11.

dorszewskaj@yahoo.com
cstt_ebm_yarden_001 Yarden Yosef The Weizmann Institute of Science Rehovot Israel

Prof. Yosef Yarden currently serves as Head of the Department of Biological Regulation of the Weizmann Institute (Rehovot, Israel) and Director of the Dwek Institute for Cancer Therapy Research. He received a PhD in molecular biology from the Weizmann Institute of Science (1985). His postdoctoral training was undertaken at Genentech, Inc., in San Francisco and at the MIT. Yarden’s research focuses on growth factors and receptor tyrosine kinases, primarily their roles in cancer progression.

yosef.yarden@weizmann.ac.il
cstt_ebm_guerra_001 Guerra Germano Department of Medicine and Health Sciences University of Molise Campobasso Italy

Doctor Germano Guerra gained M.D. Degree in 1997; Residency in Sport in 2002 and PhD Program in Clinical and Pathological Morphology in 2005. He was a Visiting Clinical Research Fellow at Molecular and Population Genetics Department of Cancer Research UK from 2003 to 2005. He was Assistant Professor of Human Anatomy from 2007 to 2016 and from 2017 to date, Associate Professor of Human Anatomy in the Faculty of Medicine and Surgery of the University of Molise. Prof. Guerra is a Member of Italian Society of Anatomy and Histology, Histochemistry and Sport Medicine.

germano.guerra@unimol.it
cstt_ebm_morte-d_001 Della-Morte David Department of Neurology University of Miami Miami FL USA 23008189700

David Della-Morte received his MD degree and his PhD from the University of Naples “Federico II”, Naples, Italy. Since 2006, Dr. Della Morte has been working in the Department of Neurology, University of Miami, FL, USA where currently he is Associate Professor. Since 2013, he is also Assistant Professor of Internal Medicine at the University of Tor Vergata, Rome, Italy. Dr. Della Morte is involved in both basic and clinical science and has authored more than 150 research articles, 10 book chapters and 1 patent. He received several awards from the AHA, and the NIH.

DMorte@med.miami.edu
cstt_ebm_almasan_001 Almasan Alexandru Department of Cancer Biology Cleveland Clinic Lerner College of Medicine Cleveland OH USA

Dr. Almasan is a Professor of Molecular Medicine at Cleveland Clinic Lerner College of Medicine and co-leader of the Case Comprehensive Cancer Center. For over 20 years, his lab has had a long-standing interest in cell death and proliferation mechanisms. The focus of his research has been on the molecular basis of the DNA damage signals incurred by mammalian cells following ionizing radiation (as a prototypical DNA-damaging agent) and more recently fludarabine (in clinical use for CLL) and cell death ligands (Apo2L/TRAIL) leading to cell death and proliferation control checkpoints, autophagy, and DNA repair. Notably, Dr. Almasan has authored more than 90 pubmed-indexed manuscripts.

almasaa@mac.com
cstt_ebm_awada_001 Awada Ahmad Oncology Medicine Department Jules Bordet Institute Brussels Belgium

Ahmad Awada is head of Medical Oncology Clinic at Jules Bordet Cancer Institute Brussels, Belgium Since 2005, he is Head of the Medical Oncology Clinic. From 2011, Dr Awada was held Associate Head of Medicine Department. He has an important clinical activity in the treatment of solid tumors and particularly breast cancer. Dr. Awada took an active part in the development of new drugs (cytotoxics, molecular-targeted therapies, immunotherapy). He is membership of several international scientific societies (ASCO, EORTC, ESMO) and Professor of Clinical Medicine at the Université Libre de Bruxelles.

He published 26 book chapters and 236 articles in international publications.

ahmad.awada@bordet.be
cstt_ebm_banerjee_001 Banerjee Debu Department of Medicine and Pharmacology, Rutgers CINJ/RWJMS Rutgers, The State University of New Jersey New Brunswick NJ USA

Dr. Banerjee has been involved in training individuals both in the lab as well through two Masters Programs that he directs in the Graduate School of Biomedical Sciences. He also teaches the Ph.D and Masters courses in the GSBS. His research interests include understanding the role of carcinoma associated fibroblasts (CAFs) in tumor growth and metastasis. He also serves on the editorial board of several journals and regularly review papers for many journals.

banerjed@rutgers.edu
Chakravarti Arnab Harvard Medical School Boston MA USA chakravarti.7@osu.edu arnab.chakravarti@osumc.edu Chen Ling Capital Medical University Beijing China chlyz34@163.com Csala Miklos Department of Medical Chemistry Semmelweis University Budapest Hungary csala.miklos@med.semmelweis-univ.hu Deaglio Silvia Department of Medical Sciences School of Medicine & Human Genetics Foundation University of Turin Turin Italy silvia.deaglio@unito.it de Bartolomeis Andrea Department of Neuroscience Medical School of Naples Federico II Naples Italy adebarto@unina.it cstt_ebm_hunter_001 Hunter Toni The Salk Institute San Diego CA USA

Tony Hunter is the Renato Dulbecco Chair in Cancer Research and an American Cancer Society Professor at the Salk Institute for Biological Studies in La Jolla. In 1979, through his work on tumor viruses, he discovered a new class of protein kinase that phosphorylates tyrosine. He has spent most of the last 35 years studying protein kinases and phosphatases, and the role of protein phosphorylation in cell proliferation and the cell cycle, and how aberrant protein phosphorylation can cause cancer. His group also works on other types of posttranslational modifications (PTMs), including ubiquitylation and sumoylation, and crosstalk between PTMs. He has received many awards for his work on tyrosine phosphorylation, and is a member of several academic societies including the US National Academy of Sciences and the Royal Society of London.

hunter@salk.edu
cstt_ebm_ishikawa_001 Ishikawa Yoshihiro Cardiovascular Research Institute Yokohama City University Yokohama Japan

Prof Ishikawa has received his MD and PhD in Yokohama City University. Currently he is working as Chair of the Cardiovascular Research Institute of Yokohama City University School of Medicine. He successfully completed his Administrative responsibilities as Dean at Yokohama. He also served as Professor of Cell Biology & Molecular Medicine and Medicine (Cardiology) as well as attending physician in cardiology at Rutgers University. He is serving as an editorial member of several reputed journals. He has authored more than 200 research articles/books. He is a member of numerous international societies such as American Heart Association, American College of Physicians, American college of Cardiology, American Society of Biochemistry and Molecular Biology, or Japanese Society of Physiology. He has been honored as Established Investigator of American Heart Association, Fellow of American College of Physician, American College of Cardiology, American Heart Association or European Society of Cardiology.

yishikaw@med.yokohama-cu.ac.jp
cstt_ebm_jeong-k-y_001 Jeong Keun-Yeong Metimedi Pharmaceuticals Co. Ltd. Incheon South Korea

Dr. Jeong received his Ph.D from Korea University Medical College in South Korea. During postdoctoral course, he investigated biochemical phenomena related to hepatocellular carcinoma-induced pulmonary metastasis in the department of radiation oncology. As a research professor, his research focused is on signal transduction related to EGFR, FAK, and Src in various solid tumors, including breast cancer, lung cancer, pancreatic cancer, and colorectal cancer. Recently, he developed anti-cancer drugs with his colleagues while conducting many cancer studies and established Metimedi Pharmaceuticals, and he has conducted various translational researches that can be clinically applied from the study in research center. He published many articles to SCI and SCIE journals through his studies and contributed to prominent international journal office as an editorial board member and reviewer.

alvirus@naver.com
cstt_ebm_jones_001 Jones Robin L. The Royal Marsden Hospital London UK

Dr. Jones is a medical oncologist specialising in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcoma. Dr Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington / Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials of novel agents and immunotherapy in sarcoma.

robin.jones4@nhs.net
Kawamata Hitoshi Department of Oral and Maxillofacial Surgery 880 Kitakobayashi Medical University School of Medicine Tochigi Japan h-kawama@dokkyomed.ac.jp cstt_ebm_kiani_001 Kiani Mohammad F. Department of Mechanical Engineering Temple University Temple University Philadelphia PA USA

Dr. Kiani is a professor in the Departments of Mechanical Engineering, Bioengineering and Department of Radiation Oncology, at Temple University. He served as the chair of Department of Mechanical Engineering at Temple University (2004-2014) and Department of Biomedical Engineering at the University of Tennessee Health Science Center (2003-2004). His expertise include microfluidics, targeted drug delivery and radiation biology. He has published more than 75 peer reviewed scientific articles and has made more than 200 presentations at scientific meetings. Dr. Kiani is a fellow of the American Heart Association.

mkiani@temple.edu
Kofler David First Department of Internal Medicine University Hospital Cologne Cologne Germany david.kofler@uni-koeln.de Müller Gerhard GPC Biotech AG Munich Germany gmueller@gothamtx.com Müller T. University Bochum Bochum Germany Niibe Yuzuru Department of Radiology Toho University Omori Medical Center Tokyo Japan joe-n@hkg.odn.ne.jp cstt_ebm_ocker_001 Ocker Matthias Bayer Pharma Aktiengesellschaft Berlin Germany

Matthias Ocker studied medicine at the University of Erlangen, Germany, where he obtained his medical doctorate degree in 2000. He got his academic training at the Department of Cellular and Molecular Physiology and the Department of Gastroenterology of the University Hospital Erlangen. He became Assistant Professor for Experimental Medicine and head of research at the Department of Gastroenterology in Erlangen and was appointed full professor of Medicine and Director of the Institute for Surgical Research at the University of Marburg in 2009. He joined Bayer as Director of Experimental Medicine Oncology in Berlin in 2012 and was appointed as VP and Head of Oncology Biomarker Strategists in 2016. He is adjunct professor of Experimental Medicine at the Charité University Hospital Berlin and has authored more than 100 scientific publications.

matthias.ocker@bayer.com
cstt_ebm_orlikosky_001 Orlikowsky Thorsten W. Department of Neonatology University of Tubingen Tubingen Germany

Dr. Orlikowsky obtained a doctorate (M.D.) in Medicine from the University of Tuebingen, Germany. Professor Thorsten Orlikowsky has been appointed as Head of the Dept. of Neonatology at the University Childrens’ Hospital in Aachen in 2008. He spent two years of his expert training in New York with Professor Michael Hoffmann under a fellowship program of the German Cancer Aid. From this work he developed his new research areas “Infection Immunology” and “Neonatal Immunology”. He studied on the development of the immunological system of premature babies, their infections and the consequences of those infections on the immune system.

torlikowsky@ukaachen.de
Papavassiliou Athanasios G. Department of Biological Chemistry National and Kapodistrian University of Athens Athens Greece gpapavas@pat.forthnet.gr papavas@med.uoa.gr cstt_ebm_paul-mk_001 Paul Manash K. Department of Medicine University of California Los Angeles CA USA

Dr. Manash Kumar Paul, is currently working as Project Scientist at University of California Los Angeles (UCLA). He has contributed significantly in the field of stem cell biology, regenerative medicine and lung cancer. His research is focused on various signaling processes involved in maintaining stem cell homeostasis during injury and repair. Recently, his group published, first in vitro method for the development of lung organoids mimicking lung from iPSCs. Dr. Paul has published in more than 20 peer reviewed international journals and his work has been highly cited. Dr. Paul is a recipient of many awards that include prestigious UCLA Vice Chancellor’s Postdoctoral award and was nominated for Paul Boyer’s award. Dr. Paul is a member of many scientific societies (ISSCR, AHA, ALA) and he is editorial member of many international journals.

manashp@ucla.edu paul_cancerbiotech@yahoo.co.in
cstt_ebm_purohit_001 Purohit Rituraj Division of Biotechnology CSIR-Institute of Himalayan Bioresource Technology Palampur India

Dr. Rituraj Purohit is a Senior Scientist at CSIR-Institute of Himalayan Bioresource Technology, India. He has nearly 11 years of experience in the academic and research area of computational structural and in-silico cancer biology. Previously, Dr. Purohit has served as Associate Professor at Vellore Institute of Technology (VIT), University and post-doctoral researcher at Human Genetics Foundation-Torino, Italy. During his career Dr. Purohit holds a Ph.D. in Bioinformatics from VIT University and a Master of Technology from the Indian Institute of Information Technology, Allahabad. Notably, Dr. Purohit has authored more than 50 manuscripts.

riturajpurohit@gmail.com
cstt_ebm_robak_001 Robak Tadeusz Department of Hematology Medical University of Lodz Ciolkowskiego Poland

Tadeusz Robak, MD, PhD, is Professor of Hematology at the Medical University of Lodz, and Head of the Department of Hematology at Copernicus Memorial Hospital in Lodz, Poland. He is Chair of the chronic lymphocytic leukaemia (CLL) subgroup of the Polish Adult Leukemia Study Group and President of the Polish Society of Hematology. His special interests are in CLL and lymphoma, with particular emphasis on the use of purine analogues and targeted drugs. Professor Robak has been selected by the World Scientists Forum of the International Research Promotion Council for the “Eminent Scientist of the Year 2010” award in haematology-oncology.

robaktad@csk.umed.lodz.pl
Shepard H. Michael Receptor BioLogix Inc. San Francisco CA USA mshepard@halozyme.com cstt_ebm_tutar_001 Tutar Yusuf Faculty of Pharmacy, Department of Basic Sciences Cumhuriyet University Sivas Turkey

Dr. Yusuf Tutar is the Head of Biochemistry Division and the Head of Basic Sciences Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey. Dr. Tutar is also the Head of Biomedical Engineering Program at the same university. He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.

ytutar@cumhuriyet.edu.tr
cstt_ebm_d-zhang_001 Zhang Dan The Third Department of Reproductive Endocrinology, Women's Hospital, School of Medicine Zhejiang University Hangzhou P.R.China

Dr. Zhang is Assistant President & Chief Physician & Associate Professor & the Director of the Third Department of Reproductive Endocrinology of Women's Hospital, School of Medicine, Zhejiang University. She also serves as the Assistant Director of Key Laboratory of Reproductive Genetics (Ministry of Education), Zhejiang University. Dr. Zhang has 15 years of experience in reproductive clinical work and research. She has authored more than 30 manuscripts, 2 patents, and has co-edited 3 books including “Gamete and Embryo-Fetal Origins of Adult Diseases” published by Springer.

zhangdan@zju.edu.cn
cstt_ebm_h-zhang_001 Zhang Hongtao Department of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine Philadelphia PA USA

Dr. Hongtao Zhang is a Research Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine. He graduated from University of Pennsylvania in 1999 with a Ph.D. degree in Pharmacology. Currently his research focus is receptor- targeted therapies using antibodies, antibody-like proteins, and small molecules. He is also devoted to the identification of serum biomarkers that can help the diagnosis and provide therapeutic guidance for breast cancer and melanoma. He has published more than 70 articles in journals including Nature Medicine and Nature Biotechnology. Dr. Zhang is listed as inventors in 12 approved patents and some other pending patents. He serves as an editorial board member for several journals.

zhanghon@mail.med.upenn.edu
cstt_ebm_s-kumar_001 Kumar Sunil Faculty of Bio-Sciences Shri Ramswaroop Memorial University Lucknow India

Dr. Sunil Kumar received his Master degree in Biotechnology from the Devi Ahilya University, Indore, (India) in 2006 and his PhD in Biotechnology from Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India in 2011. He is currently an Associate Professor at the Shri Ramswaroop Memorial University, Barabanki, Uttar Pradesh, India. His research interests include genetic engineering, molecular biology, medical microbiology particularly focused on molecular characterization of bacterial biofilm and drug development and inflammatory bowel diseases. Dr. Kumar has authored more than 40 peer-reviewed articles, eight book chapters and edited one book for springer. Dr. Kumar serves as an editorial board member and reviewer of more than 6 international journals.

sunil.bio@srmu.ac.in sunilsbt@gmail.com
Associate Editorial Board Members cstt_ebm_Shukla-sh_001 Shukla Kirtikar Orcid Department of Internal Medicine-Molecular Medicine Wake Forest School of Medicine Winston-Salem NC USA 0000-0002-1789.4990 AAR-4008-2020 https://www.ncbi.nlm.nih.gov/myncbi/kirtikar.shukla.I/bibliograplıy/pulic/ https://scholar.google.com/citations?user=f GólygAAAAJ&hl=en

Dr. Shukla is an Associate Research Scientist of Internal Medicine, Molecular Medicine Section at Wake Forest School of Medicine, Winston Salem, USA. He has published more than 21 research articles in reputed peer-reviewed journals. He is involved in an NCI-NIH Clinical trial with the Department of Cancer Biology on “Cetuximab, an EGFR on anti-PD-1 immunotherapy non-responder Head and neck patients” and in a clinical study to determine the role of Redox biomarkers in the Sepsis patient. Dr. Shukla has developed Head and neck cancer patient-derived xenograft (PDX) models, which can be used for chemotherapy drug titration and selection as potential precision medicine with reduced turnaround time. He serves as a reviewer in several scientific journals including Bentham Science- Reviews on Recent Clinical Trials, BDPI- Diagnostics, Cancer etc.

kshukla@wakehealth.edu
cstt_ebm_le-thi-thu-h-s_001 Le-Thi-Thu Huong Orcid Faculty of Pharmacy Hanoi National University Hanoi Viet Nam 0000-0002-3826-1279 https://scholar.google.com/citations?user=bgfUiGYAAAAJ&hl=en https://www.researchgate.net/profile/Huong_Le_Thi_Thu/publications

Huong Le-Thi-Thu received the PhD degree in pharmaceutical sciences from the Central University of Las Villas, Cuba, in 2012. That same year, she joined School of Medicine and Pharmacy, Vietnam National University, Hanoi (VNU), working as assistant professor at the department of Pharmacy and Pharmacology of Traditional Materials. Her research interest is on the development and application of novel approaches that integrate cheminformatics, computational biology, and bioinformatics methods with medicinal chemistry for improving personalized drug screening and reposition. She has authored more than 50 publications in peer-reviewed journals, 2 international book chapters, and various proceedings.

ltthuong1017@gmail.com
cstt_ebm_chakaro-s-h_001 Chakarov S. Orcid Department of Biochemistry Sofia University St. Kliment Ohridski Sofia Bulgaria 0000-0002-0712-9793 C-3803-2018 21833294400 https://drive.google.com/open?id=1P6DfHzAmIvvm66-3ciiRnTcQYN_1IKdI https://drive.google.com/open?id=1VL9vPnw7VcVjOnGddbXVb5PrhwBQsTz2 https://scholar.google.bg/citations?hl=en&user=Hmb2e9IAAAAJ&view_op=list_works&sortby=pubdate&gmla=AJsN-F7X-cZrftTYLAMttdy_9fqSqaADtEN5kNJNB-S6EbUyiJ8exb46PuXXg7WDmA8mOWimc4kixLFXMkMaDIctitI_W9Fgx5P0RfBBChSnOAsBLm7SBNY&sciund=10190773626240950446&gmla=AJsN-F5VEkz-rzcaK__-3A5wzxjcK46cuaySJUr3nLBdH-wcQ6kCzvW7wekMsRQ3xoApc8q4k2cX_V8p8X6EdI7q3xSF1iboHjQ4zmMPO684zg5ijpvBV1c&sciund=7016352754347909619&gmla=AJsN-F6FphGlrHHNx62xYwLZ090ZV6KyeylFd9pb7lqmCNDAjUTotBscZVEPHAGeEAIY2ssCuBtnlqVd89xHrBQ6S_hRsPsdRGcryh6NYoLbrRoj5Prr4lU&sciund=3383058829902863391&gmla=AJsN-F4CmzGJEU5FRir8Qe8psfa-EqhwSrG2MGminm8zjaqIsCEYy4RNBNEgrBNTuW5gn0Iu6u9uM9V2UC3BDrWRPu_YzIj_0w6RY70JPIi_LN53uFiC8Mg&sciund=4051384300943452021&gmla=AJsN-F7MjMuDUphQJR9_aTFdHXpPPmbznulOAgt--X8PbKVUA-jq6qnfdvmoDHBDS1s1ZcIX2Unn7eZnwyXNha8PBCWNGVgXUTQftSwwn77qieMs_XHuw&sciund=9282619771930595825 stoianchakarov@gmail.com cstt_ebm_sekar-d-ah_001 Sekar Durairaj Orcid Dental Research Cell and Biomedical Research Unit Saveetha Dental College and Hospital Saveetha Institute of Medical and Technical Sciences Saveetha University Chennai India 0000-0002-0722-8636 26030731700 https://www.ncbi.nlm.nih.gov/pubmed/?term=sekar+d https://scholar.google.co.in/citations?user=xdqFy8AAAAAJ&hl=en

Dr. Durairaj sekar Ph.D earned degrees from Tamilnadu Agricultural University, Madurai Kamaraj University, India and doctorate from University of Camerino, Italy. He worked as a post-doctoral Researcher from International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa since 2011. Currently, he is working as an Associate professor at Research Cell, Saveetha University, Chennai, India.

duraimku@gmail.com
cstt_ebm_rababa-ah_001 Rababa'h M. Abeer Orcid Department of Clinical Pharmacy Faculty of Pharmacy Jordan University of Science and Technology Irbid Jordan 0000-0003-4619-2012 https://www.researchgate.net/profile/Abeer_Rababah2 https://scholar.google.com/citations?hl=en&user=6sqVWdYAAAAJ&view_op=list_works&gmla=AJsN-F7rUN-_tlcHMZoYuzojkIG1QJqZBaYabRiZvq3549IHwjFFOPiA7NizZk6YUtrEL5FL5ZXrD5Yh-Z4BaXTsQieMS7HUw75XZJ4vFTDlfnMIqAAfJx0 http://www.just.edu.jo/eportfolio/Pages/Default.aspx?email=amrababah https://www.ncbi.nlm.nih.gov/pubmed/?term=Rababa%27h+A

Abeer Rababa’h, an associate professor of pharmacology at Jordan University of Science and Technology (JUST) department of clinical pharmacy. Dr. Rababa’h joined the faculty as an assistant professor on September 2013. She was appointed as Assistant Dean of Experiential Education in 2017. She received the Association of Arab Universities (AARU- 2017), she also received the Best Researcher Award in the field of Medical Sciences. Her research work focuses on the potential role of oxidative stress in development of cardiovascular diseases. Dr. Rababa’h has been a member of ASPET since 2012. She is a member of the Divisions of Cardiovascular Pharmacology and Molecular Pharmacology.

amrababah@just.edu.jo
cstt_ebm_abu-aakar-sh_001 Abu Bakar Mohamad H. Orcid School of Industrial Technology Bioprocess Technology Division Universiti Sains Malaysia Penang Malaysia 0000-0001-8064-695X O-4454-2016 https://www.researchgate.net/profile/Mohamad_Hafizi_Abu_Bakar

Dr. Mohamad Hafizi Abu Bakar is currently a Senior Lecturer at the Bioprocess Technology Division, School of Industrial Technology, Universiti Sains Malaysia (USM). He successfully completed his PhD study in Bioprocess Engineering at the Universiti Teknologi Malaysia (UTM) in December 2015. His research interests are devoted, but are not limited to, cellular signalling towards elucidation of pathophysiological mechanisms of metabolic diseases and their correlations with inflammation and mitochondrial dysfunction in insulin resistance, and type 2 diabetes. Recently, he has published more than 20 papers in peer-reviewed international journals and 10 papers in various international conferences.

mhafizi88@usm.my
cstt_ebm_veer-k_001 Veer Karan Department of Instrumentation & Control Engineering Dr. BR Ambedkar National Institute of Technology (NIT) Jalandhar India

Karan Veer has done his B.Tech and M.Tech in Instrumentation and Control Engineering from Kurukshetra University, Haryana, India in the year of 2005 and 2008 respectively. He received PhD in Electrical and Instrumentation Engineering from Thapar University, Patiala (India) in the year of 2015. Dr. Veer has published around 30 peer reviewed research papers (with SCI Journals) in different international journals of repute with good impact factors and 02 research books on “MG classification / prosthetic devices” also goes to his credit. At present he is working as Assistant Professor in Instrumentation and Control Engineering Department at National Institute of Technology (NIT), Jalandhar, India.

veerk@nitj.ac.in
cstt_ebm_jain-s_001 Jain Shruti ​Department of ECE Jaypee University of Information Technology Himachal Pradesh India

Dr. Shruti Jain received her PhD degree from Jaypee University of Information Technology, Waknaghat, Solan. She has an overall teaching experience of around 14 years. Prior to joining JUIT, she worked as Assistant Professor in Haryana Engineering College, Jagadhari, Ambala College of Engineering, Ambala. Dr. Jain has specialization in Biomedical Signal Processing, Computer- Aided design of FPGA and VLSI circuits, and combinatorial optimization. She has published more than 60 papers in reputed journals and 30 papers in International conferences. She is currently working as Associate Professor in the Department of Electronics and Communication Engineering, JUIT Waknaghat.

​jain.shruti15@gmail.com
Executive Guest Editors cstt_ebm_mahdi-abbasi_001 Abbasi Mahdi Department of Computer Engineering Bu-Ali Sina University Hamedan China

Mahdi Abbasi is an Associate Professor of Computer Engineering in Bu-Ali Sina University, Hamedan, Iran. He received his B.Sc. degree in Computer Engineering and M.Sc. in computer Architecture from Sharif University of Technology, Iran, in 2000 and 2005, respectively. He received his Ph.D. in Computer Architecture, from University of Isfahan, in 2012. His areas of research interest include Parallel and Distributed Computing, Fog/Edge Computing, Cloud Computing, Real time and embedded systems, and Edge Intelligence.

cstt_ebm_Cardoso-sh_001 Cardoso Andrei M. Department of Biochemistry and Molecular Biology Federal University of Fronteira Sul Medicine Course Chapeco Brazil

Dr. Cardoso is a Professor of Biochemistry and Immunology of the Medicine Course at Federal University of Fronteira Sul (Brazil). For over 10 years, her research group has a long-standing interest in the mechanisms related to the involvement of purinergic signaling and oxidative injury in various diseases, especially on many types of cancer, sepsis, as well as others non communicable diseases such as hypertension. The focus of her research has been the physiopathology mechanisms and the role of ectonucleotidases and ATP on disease development. Dr. Cardoso has authored more than 30 pubmed-indexed manuscripts.

deiaa.mc@gmail.com
© 2022 Bentham Science Publishers | Privacy Policy